Who We Are
SunJour Healthcare Corporation (SHC), a subsidiary of Golden Biotechnology Corporation
SunJour Healthcare Corporation (SHC), a subsidiary of Golden Biotechnology Corporation, is proud to be part of the history of its successful parent biotechnology corporation. SHC was established in 2012. SHC is a company dedicated to promoting better health by using innovative technologies and natural herbal ingredients. The company has consistently been devoted to biotechnology research ever since its establishment.
SHC’s vision is to continually discover and develop natural dietary supplements that will be beneficial to all mankind. At SHC, we’re passionate about producing innovative products! We make the effort to provide nutritional and supplemental information to you so you can make your own informed decisions based on your specific needs.
We have a very strict process for screening all products sold at SHC. You can be confident knowing that all the dietary supplements that you choose have been carefully reviewed and meet all of our standards.
We realize that it can be a daunting process to choose from such a wide selection, so our staff is especially well trained to answer any of your questions. So don’t be afraid to ask, we’re here for you!
The office is located half way up 101 Hudson Street’s landmark 42-story building on the 21st floor. The building is a short walk from the lively waterfront area of Jersey City’s financial district, Exchange Place. The building is easily accessible via the Hudson Bergen Light Rail in New Jersey, as well as from New York and Newark Liberty International Airport, which have a direct PATH train service.
Our parent company Golden Biotechnology Co. Ltd., located in Taiwan, is a drug development biotechnology company that was founded in 2002.
With the world’s leading drug screening platform, GBC is able to rapidly screen the effectiveness of components with the help of domestic and foreign top medical scientists to create the best team from both worlds.
2016 - Acquired the “Traditional Product” certificate for UMOOZE®.
2013 - The clinical study “Research on Benefit of UMOOZE® as an Add-on therapy in Benign Prostatic Hyperplasia (BHP)” was completed. The novel compound Antroquinonol® entered into phase II - clinical trials.
2012 - SunJour Healthcare Corporation was founded.
2011 - Golden Biotechnology Japan was established; Golden Biotechnology Corporation (Beijing) was established.
2010 - M-Guard was rebranded as ‘UMOOZE®.’ RASLE®, a concentrated Antrodia camphorata product, was launched. Antroquinonol® was used in clinical trials by the FDA IND administrated plan. Passed the human clinical trials of new drugs in Taiwan and in the United States.
2009 - Acquired three certified patents for Antroquinonol® in the United States, Korea and New Zealand. Completed pre-clinical testing, and applied for clinical trials to constantly expanding into new drug development.
2008 - Completed toxicological studies (in vitro and in vivo). Acquired 9 certified patents (in the United States, Taiwan, Singapore, England and Germany). Awarded the National Health Food Certificate issued by the Department of Health in Taiwan. Awarded the 2008 National Biotechnology and Medical Care Quality Award and the Silver Prize in Taiwan.
2007 - Golden Biotechnology Corporation was the first company to obtain a functional food license from the Department of Health in Taiwan (License #00124) for liver protection on our product, GDAC. Awarded the 2007 Symbol of National Quality in Health Food Category by the Institute for Biotechnology and Medicine Industry in Taiwan. Awarded the 2007 National Innovation Award in the Innovative Technology Category for Biotechnology and Medicine Industry in Taiwan.
2006 - The blend of Astragalus and soybean was patented and commercialized under the name M-Guard. Successfully utilized the patented solid state fermentation process to cultivate Antrodia camphorata. The major component Antroquinonol® was first identified in the extract of Antrodia camphorata and produced as a natural compound for cancer adjuvant therapies.
2005 - The blend of Astragalus and Soybean was discovered. The key bioactive compounds from Antrodia camphorata were identified.
2004 - Extracted and analyzed nutritional ingredients from native herbs. Constructed a database and explored their unique composition. Cultivated the fruiting body of Antrodia camphorata.
2003 - Successfully installed three unique screening platforms for prostate cancer, breast cancer and cardiovascular disease. Established three databanks - Fermentation Databank, Natural Product Collection Databank, and Chemical Databank.
2002 - Our parent company Golden Biotechnology Corporation was founded in September.